PD-1 can interfere with TCR/CD28 signals to suppress the immune responses of T-cell help (Tc1/Th1 skewing) in the tumor microenvironment through the PD-1/SHP-2/p-STAT1/T-bet axis [51]. Here, PDCD1 is linked to neoplasm.